Viyash Scientific Limited

As of June 30, 2026, Viyash Scientific Limited carries a market capitalization of 120.78B, placing it among publicly traded companies globally. Its enterprise value stands at 120.78B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Viyash Scientific Limited's next confirmed earnings release is scheduled for November 14, 2026.

As of June 30, 2026, Viyash Scientific Limited has 436.44M shares outstanding.

As of June 30, 2026, Viyash Scientific Limited trades at a trailing price-to-earnings ratio of 62.74.

As of June 30, 2026, Viyash Scientific Limited trades at an EV/EBITDA multiple of 21.92 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.84 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 34.04 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 120.78B versus a market cap of 120.78B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 11.32M in revenue per employee across its workforce of 2,781.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Viyash Scientific Limited recorded 1.24B in income tax expense. That works out to an effective tax rate of 36.73, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.38B, leaving 1.71B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Viyash Scientific Limited's stock has gained approximately 1.12% over the past 52 weeks. The 50-day moving average sits at 249.41, while the 200-day moving average is 233.22.

Over the twelve months ended June 30, 2026, Viyash Scientific Limited generated 31.49B in revenue and converted that into 1.71B in net income, yielding earnings per share of 5.38. EBITDA reached 5.51B, while operating income came in at 4.05B.

Over the twelve months ended June 30, 2026, Viyash Scientific Limited posted a gross margin of 53.91, reflecting its pricing power and cost economics. The operating margin of 12.85 and net profit margin of 5.44 provide insight into operational efficiency.

Viyash Scientific Limited's most recent stock split took place on February 25, 2016 with a 1:5 split ratio.